EchoGen Emulsion which uses PhaseShift technology to convert liquid emulsion into gas microbubbles in the bloodstream data

The Bothell, Wash., company announced Phase II results in 59 patients, showing significantly increased visualization of blood flow and tumors.

Read the full 207 word article

How to gain access

Continue reading with a
two-week free trial.